Literature DB >> 31042164

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

Yoko Kojima, Kelly Downing, Ramendra Kundu, Clint Miller, Frederick Dewey, Hope Lancero, Uwe Raaz, Ljubica Perisic, Ulf Hedin, Eric Schadt, Lars Maegdefessel, Tom Quertermous, Nicholas J Leeper.   

Abstract

Entities:  

Year:  2019        PMID： 31042164      PMCID： PMC6486328          DOI： 10.1172/JCI129277

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  Sex-dependent differences in the secretome of human endothelial cells.

Authors:  Maria Grazia Cattaneo; Cristina Banfi; Maura Brioschi; Donatella Lattuada; Lucia M Vicentini
Journal:  Biol Sex Differ       Date:  2021-01-07       Impact factor: 5.027

Review 2.  Efferocytosis in multisystem diseases (Review).

Authors:  Yifan Zhang; Yiru Wang; Jie Ding; Ping Liu
Journal:  Mol Med Rep       Date:  2021-11-15       Impact factor: 2.952

3.  Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.

Authors:  Jian Zhang; Xiangkai Zhao; Yunyun Guo; Zhiping Liu; Shujian Wei; Qiuhuan Yuan; Haixia Shang; Wentao Sang; Sumei Cui; Tonghui Xu; Kehui Yang; Jialin Guo; Chang Pan; Jiali Wang; Jiaojiao Pang; Tianrui Han; Yuguo Chen; Feng Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-03-31       Impact factor: 10.514
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.